Not a good buy right now: price is in a strong downtrend and trading below key support (S1 0.707), with momentum still deteriorating.
Oversold conditions (RSI ~20.7) can produce short bounces, but there is no Intellectia buy signal today and fundamentals are weakening, making the bounce riskier than it’s worth for an impatient entry.
Options imply uncertainty/fear (very high IV), not confident bullish positioning.
No near-term news catalysts and no notable hedge fund/insider accumulation signals to support a reversal.
Momentum: MACD histogram is negative (-0.0117) and expanding lower, signaling selling pressure is still increasing.
RSI: ~20.7 = deeply oversold (bounce potential), but oversold can persist in strong downtrends.
Levels: Current ~0.675 is below S1 (0.707) and hovering above S2 (0.643). A break below ~0.643 would be another technical breakdown; upside resistance sits at pivot 0.809 then 0.911.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning: Open-interest put/call at 0.12 is call-heavy (bullish leaning), but today’s volume put/call at 0.88 is closer to balanced/slightly put-leaning.
Volatility: 30D IV ~195% with IV percentile 94 = extremely elevated, implying the market is pricing large moves and high uncertainty.
Activity: Today’s option volume is elevated vs its 30D average (7.58x), suggesting speculative trading rather than stable conviction.
Takeaway: Options are signaling “big move risk” more than a clean bullish setup.
Technical Summary
Sell
7
Buy
5
Positive Catalysts
remains well above current price, implying theoretical upside if operations stabilize.
Congress/influential trading: No recent congress trading data available.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: 70.81M, down -48.94% YoY (sharp contraction).
Profitability: Net income -27.77M (down -605.07% YoY) with EPS -0.28 (down -660% YoY), showing losses widened materially.
Margins: Gross margin 19.99%, down -39.39% YoY, indicating deterioration in unit economics.
Overall: Fundamental trend is worsening, which undermines confidence in a durable bottom right now.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Canaccord (2025-11-12): Kept Hold; lowered PT to $1.50 from $1.60.
Rationale: Sees some operational value but expects limited multiple expansion until there is meaningful adjusted-EBITDA loss improvement.
Wall Street-style view summary:
Pros: Shares are depressed vs PT; potential upside if losses narrow.
Cons: Profitability trajectory and margins are deteriorating; without EBITDA improvement, rerating is unlikely—making dips vulnerable to further downside.
Wall Street analysts forecast DCGO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DCGO is 3.13 USD with a low forecast of 1.5 USD and a high forecast of 4 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast DCGO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DCGO is 3.13 USD with a low forecast of 1.5 USD and a high forecast of 4 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.696
Low
1.5
Averages
3.13
High
4
Current: 0.696
Low
1.5
Averages
3.13
High
4
Canaccord
Hold
downgrade
AI Analysis
2025-11-12
Reason
Canaccord
Price Target
AI Analysis
2025-11-12
downgrade
Hold
Reason
Canaccord lowered the firm's price target on DocGo to $1.50 from $1.60 and keeps a Hold rating on the shares. The firm said while the price target does portend upside from current levels they believe that there is some value to be had for DocGo operations however, they do not see multiple expansion from a fundamental perspective until there is meaningful adj-EBITDA loss improvement.
Canaccord
Richard Close
Hold
maintain
2025-08-21
Reason
Canaccord
Richard Close
Price Target
2025-08-21
maintain
Hold
Reason
Canaccord analyst Richard Close raised the firm's price target on DocGo to $1.60 from $1.45 and keeps a Hold rating on the shares. The firm said DocGo showed some progress with its core business in 2Q as it works to replace the waning migrant services contract(s) that should be largely wound down entering 2H;however, there is much work to be done to rightsize the organization while also ramping up new business.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for DCGO
